Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study
In approximately 4,100 individuals without cardiovascular disease followed about 20 years (Malmo), GDF-15 improved prediction of all-cause mortality beyond hs-CRP and NT-proBNP; associations with specific cardiovascular endpoints were weaker.
Evidence
7/10
Moderate Evidence
Sample
—
subjects
Duration
—
study period
Journal
American Heart Journal
Key Findings
- 01
GDF-15 improved all-cause mortality prediction beyond hs-CRP and NT-proBNP
- 02
Weaker/attenuated associations with specific cardiovascular endpoints
Structured Methods
- Study Design
- Cohort Study
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (n.d.). Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study. American Heart Journal.
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
